The report "Medical Device Contract Manufacturing Market by Device Type (IVD, Cardiovascular, Drug Delivery (Autoinjectors, Infusion Device), Diabetes Care, Orthopedic, Ophthalmology, Endoscopy, Surgical), Device Class (I, II, III), Services -Global Forecast to 2029", is projected to reach USD 149.4 billion in 2029 from USD 78.9 billion in 2023, at a CAGR of 11.4% between 2024 and 2029.
Browse 407 market data Tables and 65 Figures spread through 446 Pages and in-depth TOC on "Medical Device Contract Manufacturing Market by Device Type (IVD, Cardiovascular, Drug Delivery (Autoinjectors, Infusion Device), Diabetes Care, Orthopedic, Ophthalmology, Endoscopy, Surgical), Device Class (I, II, III), Services -Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/medical-device-contract-manufacturing-market-170622851.html
The global population is growing older, leading to an increased demand for medical devices used in diagnostics, treatment, and monitoring of age-related conditions also chronic diseases like diabetes, heart disease, and cancer are becoming increasingly prevalent worldwide, necessitating a rise in the demand for medical devices used in their management. which is expected to drive the market growth. However, stringent regulatory compliances for the approval of medical devices is expected to challenge the growth of the market.
“Based on medical device contract manufacturing devices by IVD device type, the IVD consumables segment is expected to grow at the highest CAGR during the forecast period.”
Under IVD device type, IVD consumables is forecasted to grow at the highest CAGR from 2024 to 2029. IVD consumables, the disposable components used in In Vitro Diagnostics (tests conducted outside the living body), offer several advantages that contribute to efficient and accurate medical diagnoses. IVD consumables are designed and manufactured following strict specifications, ensuring consistent performance across various tests and batches. This minimizes the risk of errors due to variations in the testing environment.
“The primary & secondary packing segment is expected to account for the largest share, by packaging & assembly services in the medical device contract manufacturing market.”
By packaging & assembly services in service segment, the medical device contract manufacturing market can be segmented into primary & secondary packing, labelling and others. The advantages of primary and secondary packaging segment by protecting the device from contamination and damage during transport, storage, and handling, is expected to drive the segment growth.
Europe was the region with the second largest market share in the medical device contract manufacturing market“
The medical device contract manufacturing market is segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East and Africa and GCC countries
Europe accounted for the second-largest share of the medical device contract manufacturing market. The apidly aging population, leading to a higher demand for medical devices used in diagnosing, treating, and monitoring age-related condition is driving the growth of the medical device contract manufacturing market in the European region.
Key players in the medical device contract manufacturing market include Flex Ltd. (Singapore), Jabil Inc. (US), TE Connectivity Ltd. (Switzerland), Sanmina Corporation (US), Nipro Corporation (Japan), Celestica Inc. (Canada), Plexus Corp. (US), Integer Holdings Corporation (US), West Pharmaceutical Services, Inc. (US), Benchmark Electronics Inc. (US), Recipharm AB (Sweden), Gerresheimer AG (Germany), Kimball Electronics Inc. (US), Nortech Systems, Inc. (US), Nemera Development S.A. (France), Viant Medical Holdings, Inc. (US), Tecomet, Inc. (US), SMC Ltd. (US), Phillips-Medisize Corporation (US), Tessy Plastics Corp. (US), Carclo Plc (UK), Nolato GW, Inc. (US), MeHow (China), Tekni-Plex (US), and Peter’s Technology (China).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
